Ironing-out mechanisms of neuronal injury under hypoxic-ischemic conditions and potential role of iron chelators as neuroprotective agents

Antioxidants and Redox Signaling

Volumn 2, Issue 3, 2000, Pages 421-435

  Sorond, Farzaneh A ^a   Ratan, Rajiv R ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON; IRON CHELATING AGENT; NEUROPROTECTIVE AGENT; OXYGEN; REGULATOR PROTEIN; TRANSFERRIN; TRANSFERRIN RECEPTOR;

BRAIN HYPOXIA; BRAIN ISCHEMIA; BRAIN METABOLISM; CELL VIABILITY; CEREBROVASCULAR ACCIDENT; HOMEOSTASIS; IRON METABOLISM; IRON STORAGE; IRON TRANSPORT; NERVE CELL LESION; NERVE CELL NECROSIS; NEUROTOXICITY; PRIORITY JOURNAL; REVIEW;

CEREBROVASCULAR ACCIDENT; ELECTRONS; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; IRON; IRON CHELATING AGENTS; MODELS, BIOLOGICAL; MODELS, CHEMICAL; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATION-REDUCTION;

EID: 0033742539     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/15230860050192206     Document Type: Review

References (106)

1. The transferrin receptor and the release of iron from transferrin
2. Age-dependent sensitivity of cultured rat glial cells to billirubin toxicity
3. Chemico-physical and functional differences between H and L chains of human ferritin
4. The effect of carbon dioxide, lidoflazin and deferoxamine upon long-term survival following cardiorespiratory arrest in rats
5. Analysis of iron-binding components in the low molecular weight fraction of rat reticulocyte cytosol
6. Endothelial cell heme oxygenase and ferritin induction in rat lung by hemoglobin in vivo
7. Brain iron: Location and function
8. Iron in the brain
9. A hemin-inducible enhancer lies 4.5 KB upstream of the mouse ferrifin H subunit
10. Kinetics of superoxide dismutase and iron catalyzed nitration of phenolics by peroxynitrite
11. Iron mobilization from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes: Possible mechanisms in inflammatory disease
12. Release of iron from ferritin by xanthine oxidase
13. Effect of acidosis and anoxia on iron delocalization from brain homogenates
14. Protective effects of combined superoxide dismutase and deferoxamine on recovery of cerebral blood flow and function after cardiac arrest in dogs
15. Iron oxidation in sheep, horse and recombinant human apoferritins
16. Iron regulation in the brain at the cell and molecular level
17. The distribution of transferrin immunoreactivity in the rat central nervous system
18. Ferritin iron mobilization by chelating agents
19. Iron-related damage in acute ischemic stroke
20. Nonprotein-bound iron in post-asphyxial reperfusion injury of the newborn
21. Regulation of ferritin and heme oxygenase synthesis in rat fibroblasts by different forms of iron
22. Role of hydrogen peroxide in hypoxia-induced erythropoietin production
23. Cell cycle blockers mimosine, ciclopirox, and deferoxamine prevent the death of PC12 cells and postmitotic sympathetic neurons after removal of trophic support
24. Failure of deferoxamine, an iron chelator, to improve neurologic outcome following complete ischemia in dogs
25. Mammalian iron transport, an unexpected link between metal homeostasis and host defense
26. Altered brain metabolism of iron as a cause of neurodegenerative disease?
27. Iron regulates cytoplasmic levels of a novel iron-responsive element-binding protein without aconitase activity
28. Characterization and expression of iron regulatory protein 2 (IRP2). Presence of multiple IRP2 transcripts regulated by intracellular iron levels
29. Iron regulates intracellular degradation of iron regulatory protein 2 by the proteosome
30. Acute therapeutic interventions: Free radical scavengers and antioxidants
31. The effect of age on the nonhaem iron in the human brain
32. Protection against tissue damage in vivo by desferroxamine: What is its mechanism of action?
33. Regulation of iron regulatory protein I during hypoxia and hypoxia/reoxygenation
34. Hypoxia post-translationally activates iron-regulatory protein 2
35. Differential modulation of the RNA-binding protein IRP-1 and IRP-2 in response to iron IRP-2 inactivation requires translation of another protein
36. Identification of the iron-responsive element for the translational regulation of human ferritin mRNA
37. Molecular control of vertebrate iron metabolism: mRNA based regulatory circuits operated by iron, nitric oxide and oxidative stress
38. Transferrin receptors in rat brain: Neuropeptide-like pattern and relationship to iron distribution
39. Demonstration and characterization of the iron regulatory protein in human brain
40. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit
41. Regulation of hypoxia-inducible factor 1 α is mediated by an oxygen dependent domain via the ubiquitin-proteosome pathway
42. Comparative study of different iron chelating agents in cold-induced brain edema
43. Activation of iron handling system within the gerbil hippocampus after cerebral ischemia
44. Regulation of the transferrin-independent iron transport system in cultured cells
45. A regulated RNA binding protein also possesses aconitase activity
46. Loop and bulge/loops in iron-responsive element isoforms influences iron regulatory protein binding. Fine-tuning of mRNA regulation?
47. Regulating the fate of mRNA: The control of cellular iron metabolism
48. The history of iron in the brain
49. Brain iron delocalization and lipid peroxidation following cardiac arrest
50. Effect of deferoxamine on late death following CPR in rats
51. Regional differences in late-onset iron deposition, ferritin, transferrin, astrocyte proliferation, and microglial activation after transient forebrain ischemia in rat brain
52. Cardiac arrest and resuscitation: Brain iron delocalization during reperfusion
53. Brain cell death following ischemia and reperfusion: A proposed biochemical sequence
54. Role of hyperglycemia-related acidosis in ischemic brain damage
55. Heme oxygenase and oxidative stress. Evidence of involvement of bilirubin as physiological protector against oxidative damage
56. Low molecular weight iron in cerebral ischemic acidosis in vivo
57. Evidence that desferrioxamine cannot enter cells by passive diffusion
58. Characterization of the constitutive forms of rat liver microsomal heme oxygenase. Only one molecular species of the enzyme is inducible
59. Neuronal overexpression of heme oxygenase-1 correlates with an attenuated exploratory behavior and causes an increase in neuronal NADPH-diaphorase staining
60. Does carbon monoxide have a physiological function?
61. Inducible expression of the erythropoietin 3’ enhancer in multiple cell lines, evidence for widespread oxygen-sensing mechanism
62. The tumor suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
63. An iron chelator is not required for reductive iron release from ferritin by radical generating systems
64. Brain iron homeostasis
65. Histochemical distribution of non-haem iron in the human brain
66. Non-ferritin, non-heme iron pools in rat tissues
67. Post resuscitation iron delocalization and malonidialdehyde production in the brain following prolonged cardiac arrest
68. Oxygen radicals in cerebral ischemia
69. Ischemia-induced brain iron delocalization: Effect of iron chelators
70. Overexpression of heme oxygenase-1 is neuroprotective in a model of permanent middle cerebral artery occlusion in transgenic mice
71. Dextran-coupled deferoxamine improves outcome in a murine model of head injury
72. Distribution and renal excretion of desferrioxamine and ferrioxamine in the dog and in the rat
73. Differential regulation of IRP1 and IRP2 by nitric oxide in rat hepatoma cell line
74. Expression and biochemical characterization of iron regulatory proteins I and 2 in Saccharomyces cerevisiae
75. Changes in iron histochemistry after hypoxic-ischemic brain injury in neonatal rat
76. Hypoxia alters iron homeostasis and induces ferritin synthesis in oligodendrocytes
77. 2
78. Nitric oxide mediates iron release from ferritin
79. The interactions of desferroxamine and hydroxypyridone compounds with haemoglobin and erythrocytes
80. Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor 1
81. Prevention of post-ischemic brain lipid conjugated diene production and neurologic injury by hydroxyethyl starch-conjugated deferoxamine
82. Cellular pool of transient ferric iron, chelatable by deferoxamine and distinct from ferritin that is involved in oxidative cell injury
83. Molecular characterization of a second iron-responsive element binding protein, iron regulatory protein2. Structure, function, and post-translational regulation
84. Hypoxia-inducible factor 1: Master regulator of O2 homeostasis
85. Hypoxia-inducible factor 1 and molecular physiology of oxygen homeostasis
86. A nuclear factor induced hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation
87. Effect of deferoxamine and allopurinol on non-protein- bound iron concentrations in plasma and cortical brain tissue of newborn lambs following hypoxia-ischemia
88. Dietary iron levels and hypoxia independently affect iron absorption in mice
89. Billirubin is an antioxidant of possible physiological importance
90. Transferrin receptor induction by hypoxia
91. Reductive release of iron from ferritin by cation free radicals of paraquat and other bipyridyls
92. Ferritin and superoxide-dependent lipid peroxidation
93. Purification and characterization of the major constitutive form of testicular heme oxygenase: The non-inducible isoform
94. Neurologic abnormalities in the first 24h following birth asphyxia are associated with increasing plasma levels of free iron and TBA-reactive species
95. Carbon monoxide: A putative neural messenger
96. Oxidative stress resulting from ultraviolet A irradiation of human skin fibroblasts leads to heme oxygenase-dependent increase in ferritin
97. Purification of a specific repressor of ferritin mRNA translation from rabbit brain
98. General involvement of hypoxia inducible factor 1 in transcriptional response to hypoxia
99. Desferioxamine induces erythropoietin gene expression and hypoxia inducible factor 1 DNA-binding activity: Implication for models of hypoxia signal transduction
100. Purification and characterization of hypoxia inducible factor 1
101. Low-Mr iron isolated from guinea pig reticulocytes as AMP-Fe and ATP-Fe complexes
102. Stimulation of IRE-BP activity of IRE by tetrahydrobiopterin and cytokine dependent induction of nitric oxide synthase
103. Iron regulates nitric oxide synthase activity by controlling nuclear transcription
104. Iron in brain function and dysfunction with emphasis on Parkinson’s disease
105. The iron-responsive element binding protein purification, cloning, and regulation in rat liver
106. Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor 1 and ATF-1/CREB and increased expression of glycolytic enzymes, P21(waf1/cip1), and erythropoietin